Exciting news for severe Covid patients having more streamlined access to leronlimab at the trial sites or via EIND no matter where they live.. Knowing they get leronlimab vs chancing placebo is great too.
Happy New Year Beasley!
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
